Haemonetics MCS+, Operation Manual

Page: 12 / 110

xii Preface
P/N 85213-30, Manual revision: B
What is the
Haemonetics
“Mobile
Collection
System”?
Using updated apheresis technology, Haemonetics has produced the MCS+, a
highly mobile, compact, lightweight total apheresis system which is as easy and
safe to use, as it is technologically advanced.
The MCS+ automated apheresis technology provides the operator with a
maximum degree of flexibility in any type of apheresis location. The components
collected such as platelets, red cells, stem cells, and plasma may be designated
for use in therapeutic transfusion. Plasma collected can also be conserved and
subsequently fractionated into plasma-derived products.
The MCS+ (Haemonetics “Mobile Collection System Plus”), consists of distinctive
“parts” which collectively function as a “whole” to produce a designated final
product. These system elements can be explained using the following distinc-
tions:
! The automated total apheresis device produced by Haemonetics called
the “MCS+”.
!
The single-use collection material manufactured by Haemonetics called a
“disposable set”.
! The collection procedure designed by Haemonetics called a “protocol”.
Once the operator has initiated an MCS+ procedure, component collection will
proceed automatically. The appropriate amount of anticoagulant solution will be
mixed in the disposable tubing with whole blood from the donor/patient.
This anticoagulated blood will be drawn into a disposable collection bowl and
separated by centrifugal force into its various components.
When the bowl reaches its collection capacity, the separated components will
exit the bowl and be directed into collection containers for conservation, or
returned to the donor/patient. This cycle is repeated until the desired amount of
selected blood components have been collected.
The choice of the disposable material will depend on the selected MCS+ collec-
tion protocol. The MCS+ technology provides the operator with the option to
infuse saline solution along with the blood components remaining in the bowl at
the end of a procedure.
Haemonetics has designed the MCS+ technology with a degree of automation
which permits the operator to interact with the device. The operator should
remain attentive to the screen messages while monitoring the status of the donor/
patient. It is possible to modify the collection procedures, based on the needs and
requirements of the individual donor/patient, as well as the apheresis center.